Abbott Says FDA Oks Navitor TAVI System To Treat Severe Aortic Stenosis : vimarsana.com

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's latest-generation transcatheter aortic valve implantation

Related Keywords

Abbott Flexnav , Drug Administration , Abbott , Ays , Navitor , Avi , Ystem , Reat , Evere , Aortic , Stenosis ,